CRMD vs. NVDA

Last updated Jun 4, 2026

CRMD (CorMedix Inc.) and NVDA (NVIDIA Corporation) are both stocks. CRMD operates in Biotechnology (Healthcare), while NVDA operates in Semiconductors (Technology). Over the past 10 years, CRMD returned -4.90%/yr vs 68.84%/yr for NVDA. At a 0.15 correlation, their price movements are largely independent.

Performance

CRMD vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CorMedix Inc. (CRMD) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRMD achieves a -29.23% return, which is significantly lower than NVDA's 15.15% return. Over the past 10 years, CRMD has underperformed NVDA with an annualized return of -4.90%, while NVDA has yielded a comparatively higher 68.84% annualized return.

CRMD

• 1D: 0.73%
• 1M: 4.18%
• YTD: -29.23%
• 6M: -20.25%
• 1Y: -34.73%
• 3Y*: 16.99%
• 5Y*: 2.01%
• 10Y*: -4.90%

NVDA

• 1D: -3.62%
• 1M: 8.20%
• YTD: 15.15%
• 6M: 19.59%
• 1Y: 52.10%
• 3Y*: 76.15%
• 5Y*: 65.05%
• 10Y*: 68.84%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRMD vs. NVDA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CRMD CorMedix Inc.	-29.23%	43.58%	115.43%	-10.90%	-7.25%	-38.76%	2.06%	12.87%	158.00%	-67.32%
NVDA NVIDIA Corporation	15.15%	38.92%	171.25%	239.02%	-50.26%	125.48%	122.30%	76.94%	-30.82%	81.99%

Correlation

The correlation between CRMD and NVDA is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.23
Correlation (3Y) Calculated over the trailing 3-year period	0.19
Correlation (5Y) Calculated over the trailing 5-year period	0.25
Correlation (10Y) Calculated over the trailing 10-year period	0.20
Correlation (All Time) Calculated using the full available price history since May 14, 2010	0.15

The correlation between CRMD and NVDA shifts across timeframes, from 0.15 (all time) to 0.25 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CRMD : $765.27M NVDA : $5.24T
EPS CRMD : $2.10 NVDA : $6.53
PE Ratio CRMD : 3.92 NVDA : 32.91
PS Ratio CRMD : 1.77 NVDA : 20.72
PB Ratio CRMD : 1.75 NVDA : 26.80
Total Revenue (TTM) CRMD : $400.05M NVDA : $253.49B
Gross Profit (TTM) CRMD : $343.39M NVDA : $187.95B
EBITDA (TTM) CRMD : $207.97M NVDA : $192.76B

Return for Risk

CRMD vs. NVDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRMD

CRMD Risk / Return Rank: 22
CRMD Sharpe Ratio Rank: 19
CRMD Sortino Ratio Rank: 23
CRMD Omega Ratio Rank: 22
CRMD Calmar Ratio Rank: 21
CRMD Martin Ratio Rank: 25

NVDA

NVDA Risk / Return Rank: 78
NVDA Sharpe Ratio Rank: 81
NVDA Sortino Ratio Rank: 77
NVDA Omega Ratio Rank: 73
NVDA Calmar Ratio Rank: 79
NVDA Martin Ratio Rank: 79

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRMD vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CorMedix Inc. (CRMD) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRMD	NVDA	Difference
Sharpe ratio Return per unit of total volatility	-0.51	1.53	-2.04
Sortino ratio Return per unit of downside risk	-0.34	2.15	-2.49
Omega ratio Gain probability vs. loss probability	0.95	1.26	-0.31
Calmar ratio Return relative to maximum drawdown	-0.56	2.59	-3.15
Martin ratio Return relative to average drawdown	-0.83	6.36	-7.19
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CRMD vs. NVDA - Sharpe Ratio Comparison

The current CRMD Sharpe Ratio is -0.51, which is lower than the NVDA Sharpe Ratio of 1.53. The chart below compares the historical Sharpe Ratios of CRMD and NVDA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CRMD	NVDA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.51	1.53	-2.04
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.03	1.27	-1.24
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.05	1.39	-1.44
Sharpe Ratio (All Time) Calculated using the full available price history	-0.04	0.63	-0.66

Drawdowns

CRMD vs. NVDA - Drawdown Comparison

The maximum CRMD drawdown since its inception was -98.28%, which is greater than NVDA's maximum drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for CRMD and NVDA.

Drawdown Indicators

	CRMD	NVDA	Difference
Max Drawdown Largest peak-to-trough decline	-98.28%	-89.72%	-8.56%
Max Drawdown (1Y) Largest decline over 1 year	-62.26%	-20.21%	-42.05%
Max Drawdown (3Y) Largest decline over 3 years	-62.26%	-36.88%	-25.38%
Max Drawdown (5Y) Largest decline over 5 years	-66.91%	-66.34%	-0.57%
Max Drawdown (10Y) Largest decline over 10 years	-94.77%	-66.34%	-28.43%
Current Drawdown Current decline from peak	-83.32%	-8.90%	-74.42%
Average Drawdown Average peak-to-trough decline	-76.98%	-36.21%	-40.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	41.81%	8.21%	+33.60%

Volatility

CRMD vs. NVDA - Volatility Comparison

CorMedix Inc. (CRMD) and NVIDIA Corporation (NVDA) have volatilities of 12.63% and 12.53%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRMD	NVDA	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.63%	12.53%	+0.10%
Volatility (6M) Calculated over the trailing 6-month period	52.14%	25.54%	+26.60%
Volatility (1Y) Calculated over the trailing 1-year period	68.84%	34.22%	+34.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	77.14%	51.69%	+25.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	91.78%	49.80%	+41.98%

Dividends

CRMD vs. NVDA - Dividend Comparison

CRMD has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CRMD CorMedix Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVDA NVIDIA Corporation	0.02%	0.02%	0.03%	0.03%	0.11%	0.05%	0.12%	0.27%	0.46%	0.29%	0.45%	1.20%

Financials

CRMD vs. NVDA - Profitability Comparison

The chart below illustrates the profitability comparison between CorMedix Inc. and NVIDIA Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CRMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a gross profit of 105.12M and revenue of 127.43M. Therefore, the gross margin over that period was 82.5%.

NVDA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a gross profit of 61.16B and revenue of 81.62B. Therefore, the gross margin over that period was 74.9%.

CRMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported an operating income of 63.66M and revenue of 127.43M, resulting in an operating margin of 50.0%.

NVDA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported an operating income of 53.54B and revenue of 81.62B, resulting in an operating margin of 65.6%.

CRMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a net income of 38.60M and revenue of 127.43M, resulting in a net margin of 30.3%.

NVDA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a net income of 58.32B and revenue of 81.62B, resulting in a net margin of 71.5%.

Frequently Asked Questions

Can I hold both CRMD and NVDA in my portfolio?

CRMD and NVDA have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRMD or NVDA?

CRMD has higher volatility (12.63%) compared to NVDA (12.53%). In terms of maximum drawdown, CRMD dropped -98.28% vs NVDA's -89.72%.

Which has better risk-adjusted returns?

NVDA currently has the higher Sharpe Ratio (1.53 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.